Vilazodone in the Treatment of Social Anxiety Disorder: A Double Blind Study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Vilazodone (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- 16 Jan 2014 Planned End Date changed from 1 Sep 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov record.
- 16 Jan 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 16 Nov 2012 New trial record